Latest News

Pharmaceutical Five things for pharma marketers to know: Friday, May 29

Five things for pharma marketers to know: Friday, May 29

Amgen prepares for pricing battle over PCSK9-inhibitor Repatha; Otsuka loses Abilify lawsuit; healthcare and pharma marketers will boost spending on digital advertising in 2015

Features Managed Markets: Medicare Marketing Confidential

Managed Markets: Medicare Marketing Confidential

The Medicare enrollment period that just concluded differed in one major way from those of years past: Marketers found, both to their delight and chagrin, that the pool of Medicare eligibles now includes many individuals perfectly comfortable with digital communications. Tom Reid shares a few thoughts on what marketers have learned—or, in some cases, should've learned

Legal/Regulatory

Teva settles pay-for-delay case for $1.2 billion

Teva reached a settlement with the Federal Trade Commission to resolve an antitrust suit that charged the drugmaker's subsidiary Cephalon with illegally blocking generic competition for narcolepsy drug Provigil.

Pharmaceutical Five things for pharma marketers to know: Thursday, May 28

Five things for pharma marketers to know: Thursday, May 28

The FBI is investigating Johnson & Johnson's morcellator; Sanofi purchased another priority review voucher; generic drug prices are falling at a slow rate

Digital Mango Health takes on chronic conditions

Mango Health takes on chronic conditions

The updated app now tracks everyday health metrics including weight, activity and glucose levels.

Features Three Technologies Driving Sales in Life Sciences

Three Technologies Driving Sales in Life Sciences

Multiple marketing channels offer an effective way to ensure that meaningful relationships can be developed with prospects and when done right can increase revenue by more than 10% while reducing costs by 25%, if not both

Therapeutic Focus Therapeutic Focus: Infectious Diseases

Therapeutic Focus: Infectious Diseases

While advances in the treatment of hep.-C have been well noted, the infectious-diseases space has seen considerably less innovation than many other therapeutic areas. Given the stubbornness of superbugs like MRSA and growing antibiotic resistance, the healthcare industry has finally turned its attention to the category. Rebecca Mayer Knutsen outlines the potential threats and solutions

Pharmaceutical Express Scripts wants cancer drugs to prove value

Express Scripts wants cancer drugs to prove value

The pharmacy benefits manager wants oncology treatments priced according to how well they treat a specific cancer as opposed to using the current one-price-fits-all approach.

Pharmaceutical

Roche diagnostic unit partnering with drugmaker on companion diagnostic

The test seeks to identify patients with metastatic pancreatic cancer and high levels of hyaluronan.

Legal/Regulatory New bill seeks to spur FDA to form clearer social media rules

New bill seeks to spur FDA to form clearer social media rules

Rep. Billy Long introduced legislation that is meant to push the FDA to implement clearer guidelines for regulating drug product information on social media.